Template:Cryptococcus Meningitis: Difference between revisions

(Convert to AntibioticDose with disease=Cryptococcosis for SMW linking)
Line 1: Line 1:
===Meningitis (not AIDs associated)===
===Meningitis (not AIDs associated)===
*Amphotericin B 0.7-1mg/kg IV q24hrs '''AND''' Flucytosine 25mg/kg PO q6hrs x 4 weeks
*{{AntibioticDose|disease=Cryptococcosis|drug=Amphotericin B|dose=0.7-1mg/kg IV q24hrs|context=Meningitis not AIDS with Flucytosine x 4 weeks|population=Adult}} '''AND''' Flucytosine 25mg/kg PO q6hrs x 4 weeks
**Followed by Fluconazole 400mg PO q24hrs x 8 weeks
**Followed by {{AntibioticDose|disease=Cryptococcosis|drug=Fluconazole|dose=400mg PO q24hrs x 8 weeks|context=Meningitis consolidation not AIDS|population=Adult}}


===Meningitis (with AIDS)===
===Meningitis (with AIDS)===
*[[Amphotericin B]] 0.7-1mg/kg IV q24hrs '''AND''' [[Flucytosine]] 25mg/kg PO q6hrs x 2 weeks
*{{AntibioticDose|disease=Cryptococcosis|drug=Amphotericin B|dose=0.7-1mg/kg IV q24hrs|context=Meningitis with AIDS with Flucytosine x 2 weeks|population=Adult}} '''AND''' [[Flucytosine]] 25mg/kg PO q6hrs x 2 weeks
**Followed by [[Fluconazole]] 400mg PO q24hrs x 8 weeks
**Followed by {{AntibioticDose|disease=Cryptococcosis|drug=Fluconazole|dose=400mg PO q24hrs x 8 weeks|context=Meningitis consolidation with AIDS|population=Adult}}
*Initiation of HAART is delayed by 2 to 10 weeks to minimize the risk of immune reconstitution syndrome
*Initiation of HAART is delayed by 2 to 10 weeks to minimize the risk of immune reconstitution syndrome

Revision as of 01:29, 20 March 2026

Meningitis (not AIDs associated)

  • Amphotericin B 0.7-1mg/kg IV q24hrs AND Flucytosine 25mg/kg PO q6hrs x 4 weeks

Meningitis (with AIDS)

  • Amphotericin B 0.7-1mg/kg IV q24hrs AND Flucytosine 25mg/kg PO q6hrs x 2 weeks
  • Initiation of HAART is delayed by 2 to 10 weeks to minimize the risk of immune reconstitution syndrome